Dissociation of Neuropathologic Findings and Cognition
Open Access
- 1 August 2007
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 64 (8) , 1193-1196
- https://doi.org/10.1001/archneur.64.8.1193
Abstract
Background The apolipoprotein E (APOE) ε2 allele has been suggested as having a protective effect and delaying the age at onset of Alzheimer disease. Objective To describe a dissociation between neuropathologic findings with normal cognition in a woman with severe Alzheimer disease with theAPOEε2/ε2 genotype. Design Case report from a community-based prospective study of persons 90 years or older (The 90+ Study). Participant A 92-year-old woman without dementia with theAPOEε2/ε2 genotype who lived independently without significant cognitive or functional loss and was a participant in The 90+ Study. She died in December 2004, and postmortem examination of her brain was performed. Intervention Neurologic examination and a battery of neuropsychological tests were performed 6 months and 1 month before death. Neuropathologic examination included Braak and Braak staging for senile plaques and neurofibrillary tangles. Results Neuropathologic examination of the brain revealed advanced senile plaque and neurofibrillary tangle disease consistent with a high likelihood of Alzheimer disease. At clinical evaluation, the participant demonstrated no dementia and only mild cognitive deficits. Conclusions TheAPOEgenotype may have contributed to maintenance of cognition despite advanced neuropathologic findings of Alzheimer disease. This case suggests that theAPOEε2 isoform may have a protective effect against cognitive decline in Alzheimer disease that may be independent from senile plaques and neurofibrillary tangles.Keywords
This publication has 23 references indexed in Scilit:
- Neuropsychological data in nondemented oldest old: The 90+ StudyJournal of Clinical and Experimental Neuropsychology, 2007
- Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcriptionJournal of Neurochemistry, 2003
- Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s DiseaseNeurobiology of Aging, 1997
- Characterization of the Binding of Amyloid‐β Peptide to Cell Culture‐Derived Native Apolipoprotein E2, E3, and E4 Isoforms and to Isoforms from Human PlasmaJournal of Neurochemistry, 1997
- Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptidesNature Genetics, 1996
- Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer diseaseNeuroscience Letters, 1994
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseNature Genetics, 1994
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988
- Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaquesAnnals of Neurology, 1988
- Prevalence of chronic disease and health practices in a retirement communityJournal of Chronic Diseases, 1986